MDCX (Medicus Pharma) 12-1 Month Momentum %: -84.87% (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDCX Medicus Pharma Ltd MDCX
12 GF Score
Price $0.17
! 2 Warning Signs
View Full Analysis

What is Medicus Pharma 12-1 Month Momentum %?

Medicus Pharma MDCX -34.40% 12 12-1 Month Momentum % is -84.87% as of Sep. 04, 2026. GuruFocus rates MDCX with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 1,015 Drug Manufacturers companies, Medicus Pharma ranks worse than 97.73% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-04), Medicus Pharma's 12-1 Month Momentum % is -84.87%.

The industry rank for Medicus Pharma's 12-1 Month Momentum % or its related term are showing as below:

MDCX's 12-1 Month Momentum % is ranked worse than
97.73% of 1015 companies
in the Drug Manufacturers industry
Industry Median: -15.23 vs MDCX: -84.87

Medicus Pharma  (NAS:MDCX) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Medicus Pharma 12-1 Month Momentum % Related Terms

MDCX vs MIRA, SCLX, NSRX: 12-1 Month Momentum % Comparison

For the Drug Manufacturers - General subindustry, Medicus Pharma's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicus Pharma 12-1 Month Momentum % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's 12-1 Month Momentum % falls into.


MDCX
12GF Score
Medicus Pharma Ltd MDCX
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Pharma  (NAS:MDCX) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of -84.87% mean?
Medicus Pharma (MDCX) has a 12-1 Month Momentum % of -84.87% as of Sep. 04, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Medicus Pharma and its competitors. According to the industry distribution chart, Medicus Pharma ranks #992 out of 1015 companies in the Drug Manufacturers industry, placing it in the top 97.7%.
Is Medicus Pharma's 12-1 Month Momentum % too high?
Medicus Pharma's current 12-1 Month Momentum % is -84.87%. Based on the distribution chart, Medicus Pharma ranks #992 out of 1015 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicus Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's 12-1 Month Momentum % compare to MIRA and SCLX?
According to the Drug Manufacturers industry distribution chart, Medicus Pharma ranks #992 out of 1015 companies for 12-1 Month Momentum %. This places Medicus Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Drug Manufacturers company?
A good 12-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Medicus Pharma and its competitors. Medicus Pharma's current 12-1 Month Momentum % is -84.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (MDCX) has a current 12-1 Month Momentum % of -84.87%. The current 12-1 Month Momentum % is -84.87%. Medicus Pharma's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current 12-1 Month Momentum % is -84.87% as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
12GF Score

Get the complete analysis for MDCX

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price